Derivation of New Human Embryonic Stem Cell Lines from Nonviable Embryos
Author Information
Author(s): Gavrilov Svetlana, Marolt Darja, Douglas Nataki C., Prosser Robert W., Khalid Imran, Sauer Mark V., Landry Donald W., Vunjak-Novakovic Gordana, Papaioannou Virginia E.
Primary Institution: Columbia University
Hypothesis
Can nonviable human embryos be used to derive new human embryonic stem cell lines?
Conclusion
Two new human embryonic stem cell lines were successfully derived from nonviable embryos, suggesting that poor quality embryos can still yield viable stem cells.
Supporting Evidence
- Two new hESC lines CU1 and CU2 were derived from nonviable embryos.
- Embryos were assessed for viability and potential for hESC derivation.
- Both hESC lines displayed typical stem-cell-like morphology and normal karyotypes.
- Retrospective analysis indicated that embryo quality at ED5 correlates with ED6 outcomes.
- Derivation efficiency from nonviable embryos was 1.25%.
Takeaway
Scientists found a way to create new stem cells from embryos that couldn't grow properly, which means we can use more embryos without wasting healthy ones.
Methodology
The study involved deriving stem cells from nonviable embryos and analyzing their potential for stem cell lines.
Limitations
The derivation efficiency from nonviable embryos was low, and in vivo differentiation was not successful.
Participant Demographics
Embryos were generated from 87 patients undergoing IVF.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website